The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Polo-like kinases: a team that plays throughout mitosis
Open accessAbstract
When the first mutant allele of the Drosophila genepolo was first characterized over 10 years ago, attention focused on the defects that centrosome behavior exhibited at various stages of development (Sunkel and Glover 1988). The subsequent realization that the serine-threonine kinase it encodes is highly conserved from yeasts to humans has provoked a flurry of investigation into the function of the enzyme. A role for the polo-like kinases (plks) in regulating centrosome behavior has been borne out in several organisms, and the enzymes have attracted further attention recently with the realization that they regulate multiple stages of mitotic progression. In this article we review the current status of our understanding of the functions of plks from the time of commitment to M phase in the activation of Cdc25, through the activation of the anaphase promoting complex (APC), to the regulation of late mitotic events essential for cytokinesis. We discuss how to reconcile the sometimes apparently disparate observations made upon plk function in different organisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,831
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,486
Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Genetic control of the cell division cycle in the fission yeast Schizosaccharomyces pombe
Nurse, P., Thuriaux, P., & Nasmyth, K. (1976) · Molecular and General Genetics MGG · doi:10.1007/bf00268085 · Cited by 910
Abnormal Centrosome Amplification in the Absence of p53
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., & Woude, G. F. V. (1996) · Science · doi:10.1126/science.271.5256.1744 · Cited by 797
Lane, H. A., & Nigg, E. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1701 · Cited by 690
Ciosk, R., Zachariae, W., Michaelis, C., Shevchenko, A., Mann, M., & Nasmyth, K. (1998) · Cell · doi:10.1016/s0092-8674(00)81211-8 · Cited by 593
Polo, a mitotic mutant of Drosophila displaying abnormal spindle poles
Sunkel, C. E., & Glover, D. M. (1988) · Journal of Cell Science · doi:10.1242/jcs.89.1.25 · Cited by 561
Self-citationCentrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity
Lingle, W. L., Lutz, W. H., Ingle, J. N., Maihle, N. J., & Salisbury, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2950 · Cited by 515
Purification and Molecular Cloning of Plx1, a Cdc25-Regulatory Kinase from Xenopus Egg Extracts
Kumagai, A., & Dunphy, W. G. (1996) · Science · doi:10.1126/science.273.5280.1377 · Cited by 507
Cited by
Mitotic kinases as regulators of cell division and its checkpoints
Nigg, E. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048096 · Cited by 1,547
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1841 · Cited by 841
Elia, A. E. H., Rellos, P., Haire, L. F., Chao, J. W., Ivins, F. J., Hoepker, K., Mohammad, D., Cantley, L. C., Smerdon, S. J., & Yaffe, M. B. (2003) · Cell · doi:10.1016/s0092-8674(03)00725-6 · Cited by 760
Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to Mitotic Substrates
Elia, A. E. H., Cantley, L. C., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1079079 · Cited by 684
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Strebhardt, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3184 · Cited by 653
Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems
Kohn, K. W. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.8.2703 · Cited by 560
DNA damage checkpoint control in cells exposed to ionizing radiation
Iliakis, G., Wang, Y., Guan, J., & Wang, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206682 · Cited by 476
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
Liu, X., & Erikson, R. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031523100 · Cited by 472
The Dissociation of Cohesin from Chromosomes in Prophase Is Regulated by Polo-like Kinase
Sumara, I., Vorlaufer, E., Stukenberg, P. T., Kelm, O., Redemann, N., Nigg, E. A., & Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00473-2 · Cited by 453
Polo-like kinase-1 is a target of the DNA damage checkpoint
Smits, V. A. J., Klompmaker, R., Arnaud, L., Rijksen, G., Nigg, E. A., & Medema, R. H. (2000) · Nature Cell Biology · doi:10.1038/35023629 · Cited by 440
Regulating mammalian checkpoints through Cdc25 inactivation
Donzelli, M., & Draetta, G. F. (2003) · EMBO reports · doi:10.1038/sj.embor.embor887 · Cited by 438
Tran, H., Brunet, A., Griffith, E. C., & Greenberg, M. E. (2003) · Science's STKE · doi:10.1126/stke.2003.172.re5 · Cited by 434
Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans
Hannak, E., Kirkham, M., Hyman, A. A., & Oegema, K. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108051 · Cited by 422
Bueno, M. J., & Malumbres, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.002 · Cited by 410
Polo-like kinases (Plks) and cancer
Takai, N., Hamanaka, R., Yoshimatsu, J., & Miyakawa, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208272 · Cited by 386
Lawo, S., Hasegan, M., Gupta, G. D., & Pelletier, L. (2012) · Nature Cell Biology · doi:10.1038/ncb2591 · Cited by 372
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
Gumireddy, K., Reddy, M. V. R., Cosenza, S. C., Nathan, R. B., Baker, S. J., Papathi, N., Jiang, J., Holland, J., & Reddy, E. P. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.009 · Cited by 367
Polo-like kinases and oncogenesis
Eckerdt, F., Yuan, J., & Strebhardt, K. (2005) · Oncogene · doi:10.1038/sj.onc.1208273 · Cited by 365
Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase
Toyoshima-Morimoto, F., Taniguchi, E., Shinya, N., Iwamatsu, A., & Nishida, E. (2001) · Nature · doi:10.1038/35065617 · Cited by 364
Checking out the G2/M transition
Smits, V. A. J., & Medema, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00204-4 · Cited by 355
Alexandru, G., Uhlmann, F., Mechtler, K., Poupart, M.-A., & Nasmyth, K. (2001) · Cell · doi:10.1016/s0092-8674(01)00362-2 · Cited by 353
MEN and SIN: what's the difference?
Bardin, A. J., & Amon, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099020 · Cited by 344
Kim, I.-M., Ackerson, T., Ramakrishna, S., Tretiakova, M., Wang, I.-C., Kalin, T. V., Major, M. L., Gusarova, G. A., Yoder, H. M., Costa, R. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3003 · Cited by 337
Nakajima, H., Toyoshima-Morimoto, F., Taniguchi, E., & Nishida, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300126200 · Cited by 337
Plk1 promotes nuclear translocation of human Cdc25C during prophase
Toyoshima‐Morimoto, F., Taniguchi, E., & Nishida, E. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf069 · Cited by 337
Vaze, M. B., Pellicioli, A., Lee, S. E., Ira, G., Liberi, G., Arbel-Eden, A., Foiani, M., & Haber, J. E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00593-2 · Cited by 335
Losada, A., Hirano, M., & Hirano, T. (2002) · Genes & Development · doi:10.1101/gad.249202 · Cited by 333
Spankuch-Schmitt, B., Bereiter-Hahn, J., Kaufmann, M., & Strebhardt, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.24.1863 · Cited by 327
Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis
Neef, R., Preisinger, C., Sutcliffe, J., Kopajtich, R., Nigg, E. A., Mayer, T. U., & Barr, F. A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200306009 · Cited by 319
Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases
Giet, R., & Prigent, C. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.21.3591 · Cited by 314
Targeted Protein Degradation and Synapse Remodeling by an Inducible Protein Kinase
Pak, D. T. S., & Sheng, M. (2003) · Science · doi:10.1126/science.1082475 · Cited by 299
Structure and function of Polo-like kinases
Lowery, D. M., Lim, D., & Yaffe, M. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208280 · Cited by 293
The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation
Walter, A. O., Seghezzi, W., Korver, W., Sheung, J., & Lees, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203847 · Cited by 293
Hinchcliffe, E. H., & Sluder, G. (2001) · Genes & Development · doi:10.1101/gad.894001 · Cited by 279
Iqbal, J., Sanger, W. G., Horsman, D. E., Rosenwald, A., Pickering, D. L., Dave, B., Dave, S., Xiao, L., Cao, K., Zhu, Q., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63284-1 · Cited by 279
Forkhead transcription factors contribute to execution of the mitotic programme in mammals
Alvarez, B., Martínez-A., C., Burgering, B. M. T., & Carrera, A. C. (2001) · Nature · doi:10.1038/35099574 · Cited by 277
Yeo-Teh, N. S. L., Ito, Y., & Jha, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061706 · Cited by 273
Polo‐like kinase 1 (PLK1) is overexpressed in primary colorectal cancers
Takahashi, T., Sano, B., Nagata, T., Kato, H., Sugiyama, Y., Kunieda, K., Kimura, M., Okano, Y., & Saji, S. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01411.x · Cited by 265
Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation
Ando, K., Ozaki, T., Yamamoto, H., Furuya, K., Hosoda, M., Hayashi, S., Fukuzawa, M., & Nakagawara, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314182200 · Cited by 264
Neef, R., Gruneberg, U., Kopajtich, R., Li, X., Nigg, E. A., Sillje, H., & Barr, F. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1557 · Cited by 257
Timing is everything: regulation of mitotic exit and cytokinesis by the MEN and SIN
McCollum, D., & Gould, K. L. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01901-2 · Cited by 254
Cheng, K.-Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg558 · Cited by 254
Requirement of Hsp90 for centrosomal function reflects its regulation of Polo kinase stability
de Cárcer, G., do Carmo Avides, M., Lallena, M. J., Glover, D. M., & González, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2878 · Cited by 90
Self-citationde Cárcer, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2214 · Cited by 66
Cdc2-mediated phosphorylation of Kid controls its distribution to spindle and chromosomes
Ohsugi, M., Tokai‐Nishizumi, N., Shiroguchi, K., Toyoshima, Y. Y., Inoue, J., & Yamamoto, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg208 · Cited by 65
ScFv‐Decorated PEG‐PLA‐Based Nanoparticles for Enhanced siRNA Delivery to Her2+ Breast Cancer
Dou, S., Yang, X., Xiong, M., Sun, C., Yao, Y., Zhu, Y., & Wang, J. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400037 · Cited by 39
Metadata
- Authors
- Glover, D. M., Hagan, I. M., & Tavares, Á. A. M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1998-12-15
- Volume
- 12
- Issue
- 24
- Pages
- 3777-3787
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W1968868084
- Cited by
- 424
- References
- 67
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.